Download PDF
J Reconstr Microsurg
DOI: 10.1055/a-2632-2621
Original Article

Tranexamic Acid in Reconstructive Microsurgery: A Systematic Review and Meta-Analysis

Evan Rothchild
1   Division of Plastic Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York
,
Isabelle T. Smith 
2   Division of Plastic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York
,
Joseph A. Ricci
2   Division of Plastic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York
› Author Affiliations
Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background

Tranexamic acid (TXA) has gained popularity across various surgical specialties for reducing perioperative blood loss. However, its role in microsurgery remains underexplored, likely due to concerns that TXA may increase the risk of thromboembolic events and compromise flap viability. Therefore, the aim of this study was to determine the impact of TXA in microsurgical reconstructive procedures.

Methods

A systematic search of the PubMed, EMBASE, Ovid MEDLINE, and Web of Science databases was conducted from their inception to September 21, 2024. Inclusion criteria were retrospective or prospective cohort studies and randomized controlled trials that administered TXA in the context of microsurgical reconstruction. Data on postoperative outcomes were extracted and pooled for meta-analysis.

Results

Five retrospective cohort studies were included, with a total of 718 patients (TXA group: 343 patients; control group: 375 patients). All studies were low-level evidence and retrospective in design, with only one including a matched control group. There was considerable variation across studies in both the microsurgical procedures performed and the timing, dosage, and route of TXA administration. The TXA group did not demonstrate an increased risk of thromboembolic events, showed a significantly decreased mean blood loss, and exhibited a trend toward reduced transfusion and hematoma rates compared to the control group.

Conclusion

Our findings provide low-level evidence that TXA use in microsurgical reconstruction does not increase the risk of thromboembolic events and may help reduce perioperative blood loss, hematoma formation, and transfusion rates. These results offer preliminary support for the safety of TXA in microsurgical reconstruction procedures and highlight its potential benefits for patients at risk of bleeding complications. However, given the limited number, heterogeneity, and low quality of available studies, these findings should be interpreted with caution. Higher-quality research is needed to support the routine use of TXA in microsurgery.

Keywords

tranexamic acid - TXA - microsurgery - microsurgical reconstruction - perioperative blood loss

Authors' Contributions

All the authors were involved in conceptualization; design; data collection, analysis, and interpretation; drafting and revision; and manuscript approval.




Publication History

Received: 28 January 2025

Accepted: 31 May 2025

Accepted Manuscript online:
11 June 2025

Article published online:
03 July 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Thamm OC, Eschborn J, Schäfer RC, Schmidt J. Advances in modern microsurgery. J Clin Med 2024; 13 (17) 5284
    Search in Google Scholar
  • 2 Tanna N, Broer PN, Weichman KE. et al. Microsurgical breast reconstruction for nipple-sparing mastectomy. Plast Reconstr Surg 2013; 131 (02) 139e-147e
    Search in Google Scholar
  • 3 Hanasono MM. Reconstructive surgery for head and neck cancer patients. Adv Med 2014; 2014: 795483
    Search in Google Scholar
  • 4 Spyropoulou A, Jeng S-F. Microsurgical coverage reconstruction in upper and lower extremities. Semin Plast Surg 2010; 24 (01) 34-42
    Search in Google Scholar
  • 5 Genden EM, Rinaldo A, Suárez C, Wei WI, Bradley PJ, Ferlito A. Complications of free flap transfers for head and neck reconstruction following cancer resection. Oral Oncol 2004; 40 (10) 979-984
    Search in Google Scholar
  • 6 Nelson JA, Fischer JP, Grover R. et al. The impact of anemia on microsurgical breast reconstruction complications and outcomes. Microsurgery 2014; 34 (04) 261-270
    Search in Google Scholar
  • 7 McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012; 72 (05) 585-617
    Search in Google Scholar
  • 8 Kim C, Park SS, Davey JR. Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence. J Blood Med 2015; 6: 239-244
    Search in Google Scholar
  • 9 Opoku-Anane J, Vargas MV, Marfori CQ, Moawad G, Maasen MS, Robinson JK. Intraoperative tranexamic acid to decrease blood loss during myomectomy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 2020; 223 (03) 413.e1-413.e7
    Search in Google Scholar
  • 10 Goobie SM, Meier PM, Pereira LM. et al. Efficacy of tranexamic acid in pediatric craniosynostosis surgery: A double-blind, placebo-controlled trial. Anesthesiology 2011; 114 (04) 862-871
    Search in Google Scholar
  • 11 Murphy GR, Glass GE, Jain A. The efficacy and safety of tranexamic acid in cranio-maxillofacial and plastic surgery. J Craniofac Surg 2016; 27 (02) 374-379
    Search in Google Scholar
  • 12 Murao S, Nakata H, Roberts I, Yamakawa K. Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: A systematic review and meta-analysis. Crit Care 2021; 25 (01) 380
    Search in Google Scholar
  • 13 Roberts I, Shakur H, Coats T. et al. The CRASH-2 trial: A randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 2013; 17 (10) 1-79
    Search in Google Scholar
  • 14 Shakur H, Roberts I, Fawole B. et al.; WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet 2017; 389 (10084): 2105-2116
    Search in Google Scholar
  • 15 Dettori JR. Spine Treatment Appraisal Report (STAR): Tranexamic acid in patients undergoing noncardiac surgery: The POISE-3 Trial. Global Spine J 2022; 12 (08) 1982-1984
    Search in Google Scholar
  • 16 Brown S, Brown T, Rohrich RJ. Clinical applications of tranexamic acid (TXA) in plastic and reconstructive surgery. Plast Reconstr Surg 2024; 154 (06) 1253e-1263e
    Search in Google Scholar
  • 17 Yao A, Wang F, Benacquista T. et al. Topical tranexamic acid does not reduce hematoma in reduction mammaplasty: A double-blind randomized controlled trial. Plast Reconstr Surg 2024; 154 (01) 30-37
    Search in Google Scholar
  • 18 Huynh MNQ, Wong CR, McRae MC, Voineskos S, McRae MH. The effects of tranexamic acid in breast surgery: A systematic review and meta-analysis. Plast Reconstr Surg 2023; 152 (06) 993e-1004e
    Search in Google Scholar
  • 19 Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014; 29 (08) 1512-1515
    Search in Google Scholar
  • 20 Cvetanovich GL, Fillingham YA, O'Brien M. et al. Tranexamic acid reduces blood loss after primary shoulder arthroplasty: A double-blind, placebo-controlled, prospective, randomized controlled trial. JSES Open Access 2018; 2 (01) 23-27
    Search in Google Scholar
  • 21 Lardi AM, Dreier K, Junge K, Farhadi J. The use of tranexamic acid in microsurgery-is it safe?. Gland Surg 2018; 7 (Suppl. 01) S59-S63
    Search in Google Scholar
  • 22 Klifto KM, Hanwright PJ, Sacks JM. Tranexamic acid in microvascular free flap reconstruction. Plast Reconstr Surg 2020; 146 (04) 517e-518e
    Search in Google Scholar
  • 23 Covidence. Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation. Accessed June 16, 2025 at: www.covidence.org
  • 24 Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 2019; 22 (04) 153-160
    Search in Google Scholar
  • 25 Leow SH, Arnaout A, Ridha H. A retrospective unicentric cohort study, evaluating the impact of tranexamic acid on autologous free flap tissue reconstruction. J Plast Reconstr Aesthet Surg 2023; 102: 514-517
    Search in Google Scholar
  • 26 Moursi AAM, Ibrahim M, Awad GA. Safety and clinical outcomes associated with the routine use of tranexamic acid (TXA) in abdominal-based free flap autologous breast reconstruction—a case control study. Eur J Plast Surg 2023; 46 (04) 533-540
    Search in Google Scholar
  • 27 Rose K, Edalatpour A, Gunderson KA, Michelotti BF, Poore SO, Gast K. Topical tranexamic acid (TXA) decreases time to drain removal, wound healing complications, and postoperative blood loss in autologous breast reconstruction: A retrospective study. Plast Surg (Oakv) 2024; 32 (03) 395-403
    Search in Google Scholar
  • 28 Valerio IL, Campbell P, Sabino J. et al. TXA in combat casualty care–does it adversely affect extremity reconstruction and flap thrombosis rates?. Mil Med 2015; 180 (3 Suppl): 24-28
    Search in Google Scholar
  • 29 Taeuber I, Weibel S, Herrmann E. et al. Association of intravenous tranexamic acid with thromboembolic events and mortality: A systematic review, meta-analysis, and meta-regression. JAMA Surg 2021; 156 (06) e210884
    Search in Google Scholar
  • 30 Heyns M, Knight P, Steve AK, Yeung JK. A single preoperative dose of tranexamic acid reduces perioperative blood loss: A meta-analysis. Ann Surg 2021; 273 (01) 75-81
    Search in Google Scholar
  • 31 Grocott MPW, Murphy M, Roberts I, Sayers R, Toh CH. UK Royal Colleges Tranexamic Acid in Surgery Implementation Group. Tranexamic acid for safer surgery: The time is now. Br J Surg 2022; 109 (12) 1182-1183
    Search in Google Scholar
  • 32 Hill JB, Patel A, Del Corral GA. et al. Preoperative anemia predicts thrombosis and free flap failure in microvascular reconstruction. Ann Plast Surg 2012; 69 (04) 364-367
    Search in Google Scholar
  • 33 Tu CH, Hong SF. Preoperative anemia: Predictor of free flap reconstruction complications in head and neck cancer. Chin J Physiol 2023; 66 (01) 21-27
    Search in Google Scholar
  • 34 Glass GE, Nanchahal J. Why haematomas cause flap failure: an evidence-based paradigm. J Plast Reconstr Aesthet Surg 2012; 65 (07) 903-910
    Search in Google Scholar
  • 35 Chen YF, Wang TH, Chiu YH, Chang DH. Postoperative hematoma in microvascular reconstruction of the head and neck. Ann Plast Surg 2018; 80 (2S Suppl 1): S15-S20
    Search in Google Scholar
  • 36 Nahabedian MY, Momen B, Manson PN. Factors associated with anastomotic failure after microvascular reconstruction of the breast. Plast Reconstr Surg 2004; 114 (01) 74-82
    Search in Google Scholar
  • 37 Vincent A, Sawhney R, Ducic Y. Perioperative care of free flap patients. Semin Plast Surg 2019; 33 (01) 5-12
    Search in Google Scholar
  • 38 Bui DT, Cordeiro PG, Hu Q-Y, Disa JJ, Pusic A, Mehrara BJ. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 2007; 119 (07) 2092-2100
    Search in Google Scholar
  • 39 Pathak N, Bovonratwet P, Purtill JJ. et al. Incidence, risk factors, and subsequent complications of postoperative hematomas requiring reoperation after primary total hip arthroplasty. Arthroplast Today 2022; 19: 101015
    Search in Google Scholar
  • 40 Liu H, Liu J, Wu Y. et al. Analysis of the risk factors for free flap necrosis in soft tissue reconstruction of the lower limbs. Orthop Surg 2023; 15 (06) 1534-1540
    Search in Google Scholar
  • 41 Min K, Hong JP, Suh HP. Risk factors for partial flap loss in a free flap: A 12-year retrospective study of anterolateral thigh free flaps in 303 lower extremity cases. Plast Reconstr Surg 2022; 150 (05) 1071e-1081e
    Search in Google Scholar
  • 42 Merchant A, Speck NE, Michalak M, Schaefer DJ, Farhadi J. Comparing seroma formation at the deep inferior epigastric perforator, transverse musculocutaneous gracilis, and superior gluteal artery perforator flap donor sites after microsurgical breast reconstruction. Arch Plast Surg 2022; 49 (04) 494-500
    Search in Google Scholar
  • 43 Boissiere F, Gandolfi S, Riot S. et al. Flap venous congestion and salvage techniques: A systematic literature review. Plast Reconstr Surg Glob Open 2021; 9 (01) e3327
    Search in Google Scholar
  • 44 Ouyang SB, Wu ZH, Zhang YP, Lu XL. Comprehensive analysis of risk factors for flap necrosis in free flap reconstruction of postoperative tissue defects in oral and maxillofacial tumors. Sci Rep 2024; 14 (01) 18676
    Search in Google Scholar
  • 45 Tejler G, Aspegren K. Complications and hospital stay after surgery for breast cancer: a prospective study of 385 patients. Br J Surg 1985; 72 (07) 542-544
    Search in Google Scholar
  • 46 Roberts I, Murphy MF, Moonesinghe R. et al.; UK Royal Colleges Tranexamic Acid in Surgery Implementation Group. Wider use of tranexamic acid to reduce surgical bleeding could benefit patients and health systems. BMJ 2024; 385: e079444
    Search in Google Scholar
  • 47 Richardson MK, Liu KC, Mayfield CK, Kistler NM, Lieberman JR, Heckmann ND. Tranexamic acid is safe in patients with a history of venous thromboembolism undergoing total joint arthroplasty. J Bone Joint Surg Am 2024; 106 (01) 30-38
    Search in Google Scholar
  • 48 Sabbag OD, Abdel MP, Amundson AW, Larson DR, Pagnano MW. Tranexamic acid was safe in arthroplasty patients with a history of venous thromboembolism: A matched outcome study. J Arthroplasty 2017; 32 (9S): S246-S250
    Search in Google Scholar
  • 49 Liang JQ, Rong TH, Liu HZ. et al. Topical injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in degenerative lumbar scoliosis surgery. Orthop Surg 2020; 12 (01) 67-73
    Search in Google Scholar
  • 50 Wong J, Abrishami A, El Beheiry H. et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 2010; 92 (15) 2503-2513
    Search in Google Scholar
  • 51 De Bonis M, Cavaliere F, Alessandrini F. et al. Topical use of tranexamic acid in coronary artery bypass operations: a double-blind, prospective, randomized, placebo-controlled study. J Thorac Cardiovasc Surg 2000; 119 (03) 575-580
    Search in Google Scholar
  • 52 Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Pérez-Chrzanowska H, Figueredo-Zalve R. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 2014; 96 (23) 1937-1944
    Search in Google Scholar
  • 53 Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 2014; 21 (06) 987-993
    Search in Google Scholar